参考文献:1. Zeng MD. The strategy for the treatment of hepatic fibrosis. Chin J Hepatol 2001;9(2): 68鈥?9. 2. Wang BE. Treatment of hepatic fibrosis with traditional Chinese medicine. Chin J Hepatol 2001;9(2): 120鈥?21. 3. Prevention and treatment program for virus hepatitis (Provisional). Chin J Infect Dis 1995; 13(4): 241. 4. Ninomiya T, Yoon S, Hayashi Y, et al. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-伪; histological evaluation by a modified histological activity index scoring system. J Gastroenterol 1998;13(1): 68. 5. Bcher Wo, Dekel B, Schwerin W, et al. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte response by therapeutic vaccination in the trimera mouse model of chronic HBV infection. Eur J Immunol 2001;21: 2071鈥?079. CrossRef 6. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the knodell histology activity index and beyond. Hepatology 2000; 31: 241鈥?46. CrossRef 7. Gan LW, Wang GJ, Li YL, et. al. Effect of Kushengjian on liver fibrosis in rats. Acad J Second Milit Med Univ 1999;20 (3): 445鈥?48.
作者单位:Chen Xiao-yin (1) Li En-qing (1) Yang Qin-he (1) Zhang Qun (2) Sun Li (1) Xu Yun-sheng (1) Shen Qiang (3)
1. Department of TCM, Medical College, Jinan University, 510632, Guangzhou 2. College of Life Science and Tech-nology, Jinan University, Guangzhou 3. The Fourth Department of the First Affiliated Hospital, Guangzhou University of TCM, China